Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 30 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact30 DOIs

Deposit reference lists for 5 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact5 DOIs

DOIs for this ISSN

Showing the top 5 of 247 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Sickle Cell Disease, a Review (10.3390/hemato3020024)	ORCID	45.49	65
2	Mechanisms of Organ Damage and Novel Treatment Targets in AL… (10.3390/hemato3010005)	ORCID	29.40	14
3	Role and Modulation of NK Cells in Multiple Myeloma (10.3390/hemato2020010)	ORCID	22.58	7
4	Monitoring Patients with Light Chain (AL) Amyloidosis during… (10.3390/hemato3010008)	ORCID	22.58	7
5	Geographic Prevalence Patterns and Modifiable Risk Factors f… (10.3390/hemato4040027)	ORCID	22.58	7
6	Current Status of CAR-T Cell Therapy in Multiple Myeloma (10.3390/hemato2040043)	ORCID	21.13	6
7	Impaired Hematopoiesis after Allogeneic Hematopoietic Stem C… (10.3390/hemato2010002)	ORCID	19.45	5
8	The AL Amyloid Fibril: Looking for a Link between Fibril For… (10.3390/hemato2030032)	ORCID	19.45	5
9	TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic… (10.3390/hemato3040050)	ORCID	19.45	5
10	The Current Understanding of and Treatment Paradigm for Newl… (10.3390/hemato2040051)	ORCID	17.47	4
11	Patterns of Blood Transfusion in Sickle Cell Disease Hospita… (10.3390/hemato5010004)	ORCID	17.47	4
12	Will Mass Spectrometry Replace Current Techniques for Both R… (10.3390/hemato2040052)	ORCID	15.05	3
13	miR-494 in Extracellular Vesicles as a Potent Biomarker of C… (10.3390/hemato3020026)	ORCID	15.05	3
14	The Role of Autologous Stem Cell Transplantation in the Trea… (10.3390/hemato5020012)	ORCID	15.05	3
15	Pica Syndromes and Iron Deficiency Anemia Treatment: A Mini… (10.3390/hemato6030026)	ORCID	11.93	2
16	Anticoagulation for Splanchnic Vein Thrombosis in Myeloproli… (10.3390/hemato2020015)	ORCID	7.53	1
17	Role of 18F-FDG PET/CT in the Management of Patients Affecte… (10.3390/hemato2020024)	ORCID	7.53	1
18	Antigen Receptors Gene Analysis for Minimal Residual Disease… (10.3390/hemato4010004)	ORCID	7.53	1
19	Extracorporeal Photopheresis in Graft-Versus-Host Disease: R… (10.3390/hemato6010002)	ORCID	7.53	1
20	Bloods—An Open Access Journal of Hematology (10.3390/bloods1010001)		0.00	0
21	Welcome to Bloods—An International Open Access Journal (10.3390/bloods1010002)	References	0.00	0
22	Recent Advancements in Hematology: Knowledge, Methods and Di… (10.3390/bloods1010003)	References	0.00	0
23	Classification of Tumors of the Hematopoietic and Lymphoid T… (10.3390/bloods1010004)		0.00	5
24	Recent Advancements in Hematology: Knowledge, Methods and Di… (10.3390/bloods1010005)		0.00	0
25	Doxorubicin Enhances Procoagulant Activity of Endothelial Ce… (10.3390/bloods1010006)		0.00	1
26	Change of Title: Bloods Becomes Hemato (10.3390/hemato1010007)	References ORCID	0.00	0
27	The Next Step for MRD in Myeloma? Treating MRD Relapse after… (10.3390/hemato1020008)		0.00	4
28	Passive Coagulability Assay Based on Coherence-Gated Light S… (10.3390/hemato1020009)		0.00	2
29	The Management of Hematologic Patients with Bloodstream Infe… (10.3390/hemato1020010)		0.00	3
30	Indoleamine 2,3-Dioxygenase Activity Is Increased in Myelody… (10.3390/hemato1020011)		0.00	0
31	Why Immunotherapy Fails in Multiple Myeloma (10.3390/hemato2010001)		0.00	8
32	Individualised Risk Assessments for Recurrent Venous Thrombo… (10.3390/hemato2010003)		0.00	4
33	Recent Advancements in Hematology: Knowledge, Methods and Di… (10.3390/hemato2010004)		0.00	1
34	Decades of Progress in Allogeneic Stem Cell Transplantation… (10.3390/hemato2010005)		0.00	1
35	On the Shoulders of a Giant: Contributions of Thomas Grogan,… (10.3390/hemato2010006)	ORCID	0.00	0
36	Immunotherapy with Antibodies in Multiple Myeloma: Monoclona… (10.3390/hemato2010007)		0.00	2
37	Precision Medicine Treatment in Acute Myeloid Leukemia Is No… (10.3390/hemato2010008)		0.00	4
38	Human Bone Marrow Mesenchymal Stromal Cell-Derived CXCL12, I… (10.3390/hemato2010009)		0.00	1
39	Integrative Statistics, Machine Learning and Artificial Inte… (10.3390/hemato2020011)		0.00	20
40	Donor Lymphocyte Infusion to Enhance the Graft-versus-Myelom… (10.3390/hemato2020012)		0.00	2
41	Current State and Challenges in Development of Targeted Ther… (10.3390/hemato2020013)		0.00	1
42	The Effect of BCR-ABL Specific Tyrosine Kinase Inhibitors on… (10.3390/hemato2020014)		0.00	0
43	A Score for Predicting Freedom from Progression of Children… (10.3390/hemato2020016)		0.00	0
44	Diffuse Large B-Cell Lymphoma: Recognition of Markers for Ta… (10.3390/hemato2020017)		0.00	3
45	Can Novel Insights into the Pathogenesis of Myeloproliferati… (10.3390/hemato2020018)		0.00	8
46	Inflammatory and Immune Disorders Associated with Myelodyspl… (10.3390/hemato2020019)		0.00	10
47	Hemophagocytic Syndrome in a Patient with ALL: Morphology St… (10.3390/hemato2020020)		0.00	1
48	Arrhythmias and Cardiogenic Shock: A Rare Disease Presentati… (10.3390/hemato2020021)		0.00	0
49	The Moderating Effect of Parenting on Adaptation of Children… (10.3390/hemato2020022)		0.00	1
50	The Clinical and Biological Effects of PD-1 Expression on Tu… (10.3390/hemato2020023)		0.00	3